BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31204944)

  • 1. [Short-Term Therapeutic Efficacy, Survival Time and Side Effects in Treatment of Newly Diagnosed Multiple Myeloma Patients with Different Chemotherapeutic Regimens].
    Pan PJ; Luo ZQ; Zhang ML
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):855-859. PubMed ID: 31204944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of CTD and PCD regimens in treatment of patients with newly diagnosed multiple myeloma].
    Gu Y; Yuan YH; Shi QL; Qu XY; Xu J; Guo R; Xu JD; Li JY; Chen LJ
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):279-284. PubMed ID: 28468087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlation of IgG Levels at Initial Diagnosis with Clinical Efficacy and Prognosis in 66 Patients with IgG Multiple Myeloma].
    Nian FG; Li F; Shao LJ; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1159-1165. PubMed ID: 31418373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of MRD Status in Newly Diagnosed MM Patients with VGPR and Above after Treatment on Clinical Prognosis].
    Yu X; Zhang KJ; Wu XJ; Shi LJ; Lin HZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1631-1636. PubMed ID: 33067965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of Combination with 1q21 Amplification or-No in Patients with Newly Diagnosed MM on the Clinical Effecacy of Bortezomib-based induction chemotherapy and Long-Term Prognosis of Patients].
    Gu WW; Wang JS; Mu K; Ren G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1251-1255. PubMed ID: 32798407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical analysis of 69 newly diagnosed multiple myeloma patients with renal insufficiency].
    An N; Li X; Shen M; Chen SL; Huang ZX
    Zhonghua Nei Ke Za Zhi; 2016 Oct; 55(10):764-768. PubMed ID: 27686436
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation and Comparison of Thromboelastography and Conventional Coagulation Tests for Blood Coagulation Function in Children with Henoch-Schönlein Purpura].
    Xiao HF; Dong ZG; Xu WQ; Chen XY; Xin PL; Zhang JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):850-854. PubMed ID: 31204943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cohort study comparing the efficacy and safety of bortezomib plus dexamethasone versus bortezomib, epirubicin and dexamethasone in patients with multiple myeloma].
    Hao QY; Chen H; Liu KY; Wen L; Huang XJ; Lu J
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):689-94. PubMed ID: 27586976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Features and Response to Treatment in Newly Diagnosed Multiple Myeloma Patients with Deletion 17P].
    Liu Y; Ke XY; Wang J; Wang YF; Dong F; Tian L; Wan W; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):802-806. PubMed ID: 28641639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-Weekly 1.6 mg/m
    Tang Y; Yu YH; Yao YY; Zou LF; Dou HJ; Wang L; Zhu Q
    Indian J Hematol Blood Transfus; 2017 Mar; 33(1):22-30. PubMed ID: 28194052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A prospective multi-center trial of non-interventional and observational study of lenalidomide in Chinese patients with multiple myeloma].
    Wang GM; Yang GZ; Huang ZX; Zhong YP; Jin FY; Liao AJ; Wang XM; Fu ZZ; Liu H; Li XL; Zhou JF; Zhang X; Hu Y; Meng FY; Huang XJ; Chen WM; Lu J
    Zhonghua Nei Ke Za Zhi; 2017 Jul; 56(7):500-506. PubMed ID: 28693058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment options and prognosis in newly diagnosed multiple myeloma patients].
    Wang L; Tang W; Wang Y; Xu L; Zhao WL; Wu W; Chen YB; Shen ZX; Hu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):308-12. PubMed ID: 21729598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma].
    Huang B; Li J; Liu J; Gu J; Zheng D; Xu D; Zou W; Wang H
    Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):865-72. PubMed ID: 25586356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of Curative Efficacy of Different Chemotherapy Regimen Combined with Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation on Multiple Myeloma].
    Wang CB; Bai H; Xi R; Pan YZ; Wu T; Xu SF; Zhang Q; Zhou JM; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1675-1680. PubMed ID: 30501703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of Bortezomib for Maintenance therapy of Patients with Multiple Myeloma].
    Gao LX; Jia XL; Hu J; Zhang YZ; Wu KX; Fu MW; Wang YX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1101-1104. PubMed ID: 28823276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and Influencing Factors of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Retrospective Analysis].
    Zhang BL; Zhou J; Zhang GL; Gui RR; Lin QD; Zu YL; Yu FC; Zhao HF; Li Z; Wang J; Fu YW; Zhang LN; Zhou H; Fang BJ; Song YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1414-1419. PubMed ID: 30295260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
    Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective study.
    Kaufman JL; Nooka A; Vrana M; Gleason C; Heffner LT; Lonial S
    Cancer; 2010 Jul; 116(13):3143-51. PubMed ID: 20564642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Efficacy and Safety of Different Doses of Dexamethasone Combined with Bortezomib and Thalidomide for Treating Patients with Multiple Myeloma].
    Li CS; Ji Y; Zhang WP; Fu LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):836-841. PubMed ID: 29950229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bortezomib combined with other drugs for treating 60 cases of multiple myeloma].
    Zhong YP; Chen SL; Li X; Hu Y; Zhang JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):214-7. PubMed ID: 19236782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.